Project description:Chronic pruritis is a common and debilitating symptom that can manifest in multiple conditions. The goal of this study was to examine populations of circulating immune cells at the single cell level from patients with different pruritic conditions and compare them to healthy controls to identify possible biomarkers or therapeutic targets for chronic pruritis.
Project description:The experiment adresses primary material from pneumonia, malaria, COPD and healthy patients. The transcriptome anaylsis shall shed light on the host response to the different pathologic conditions and hightlight key differences. Investigated cells (PBMCs) were obtained from patient blood by gradient centrifugation.
Project description:Purpose: The senescence-associated secretory phenotype (SASPs) might increase risk of age-related diseases and concomitant diseases in elderly rheumatoid arthritis (ERA) patients. This study aims to investigate the SASPs in peripheral blood mononuclear cells (PBMCs) for ERA patients. Methods: We performed RNA-seq of the PBMCs from 5 aged RA (RA_A) and 4 young RA (RA_Y) patients. By comparing the differentially expressed genes (DEGs) of RA_Y and RA_A using DESeq package, we identified the senescent secretory phenotype of ERA. The Gene Ontology (GO) functional enrichment, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses and GSEA analysis were performed using clusterProfiler package. The significant protein–protein interaction (PPI) networks identified by Cytoscape. The proteomics data that investigate secretory phenotype of ERA was download from proteomics database. The overlapping SASPs at the intersection of proteomic and transcriptomic were then validated using real-time PCR (RT-PCR). Results: The PBMCs of RA_A and RA_Y had heterogeneity transcriptomic feature. By comparing RA_A with RA_Y groups, 348 up-regulated and 363 down-regulated DEGs were identified. Gene functional enrichment indicated that up-regulated DEGs in RA_A, SASPs for ERA patients, enriched in PI3K-Akt signaling pathway, MAPK signaling pathway, toll-like receptor family, neutrophil degranulation and immune-related pathways and so on. GSEA analysis indicated, humoral immune response pathways were activated in RA_A. By performing RT-PCR, these five SASPs, SPTA1, SPTB, VNN1, TNXB, KRT1, in PBMCs of RA patients were finally validated. Conclusion: Our study revealed the aging phenotypes in PBMCs of RA patients, and validated five SASPs, which providing novel insights for targeting SASPs therapy.
Project description:Transcriptional profiling of human PBMCs comparing healthy controls, patients with diabetic nephropathy and patients with ESRD. PBMCs were analyzed as they mediate inflammatory injury. Goal was to determine effects of increasing severity of diabetic nephropathy on global PBMC gene expression. Microarray analysis of PBMCs taken from patients with varying degrees of diabetic nephropathy.
Project description:The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological pathogen of coronavirus disease 2019 (COVID-19), a highly contagious disease, spreading quickly and threatening global public health. The symptoms of the disease vary from mild reactions to severe respiratory distress or even fatal outcomes probably due to the different status of innate immunity which is the first line to combat the virus. Here in the study, we unveiled the underlying transcriptional patterns of peripheral blood mononuclear cells (PBMCs) using SARS-CoV-2 infected patients with different severity and outcome. Through systemic analysis, an anti-microbe peptide, α-defensin-1 (DEFA1) was identified to be elevated in both plasma and PBMCs in COVID19 patients, and the function and mechanism is studied.
Project description:Comprehensively compare the transcriptional difference in PPD stimulated PBMCs from individuals with different tuberculosis infectious status: tuberculosis patients, latent infectious individuals and healthy controls using the microarray analysis. Two-condition experiment, PBMCs vs. PPD-PBMCs. 12 individuals: 4 TB patients, 4 latent infectious individuals and 4 healthy controls.